X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Food sector: HLL trims growth - Views on News from Equitymaster
 
 
  • PRINT
  • E-MAIL
  • FEEDBACK
  • A  A  A
  • Aug 14, 2001

    Food sector: HLL trims growth

    The Indian food and beverages sector reported a reasonable performance in the June quarter considering the difficult market conditions. In a sample that comprised Hindustan Lever, SmithKline Beecham, Nestle, Cadbury, Britannia and Tata Tea, the topline recorded a 4% growth but the sample bottomline surged by nearly 44%.

    (Rs m) June Q01 June Q02 Change
    Net sales 41,116 42,719 3.9%
    Other Income 866 1,069 23.5%
    Expenditure 35,850 36,619 2.1%
    Operating Profit (EBDIT) 5,267 6,100 15.8%
    Operating Profit Margin (%) 12.8% 14.3%  
    Interest 160 129 -19.3%
    Depreciation 599 623 4.0%
    Profit before Tax 5,374 6,418 19.4%
    Tax 1,490 1,631 9.5%
    Extraordinary net income 240 1,138 374.8%
    Profit after Tax/(Loss) 4,124 5,925 43.7%
    Net profit margin (%) 10.0% 13.9%  
    Diluted No. of Shares (eoy) (m) 2462.2 2462.2  
    Diluted Earnings per share* 6.7 9.6  
    *(annualised)      
    Current P/e ratio   24.5  

    The huge 44% jump in net profits however, includes Rs 1,138 m that these companies earned as extraordinary income. If we take out the extraordinary income effect from the bottomline, the growth is around 23% YoY. A large part of the extraordinary income has been contributed to the sector sample by HLL.

    The sector's operating margins improved by 150 basis points to 14.3%. This came on the back of cost cutting and improving efficiencies. With tough market conditions facing them, the sector stalwarts seemed to have concentrated on controlling costs and reducing the debt burden to maintain bottomline growth.

    Excluding HLL's numbers, the topline growth for the sample was a much better 8.8% and the bottomline growth stood at nearly 30% (excluding extraordinary income). This data further underlines the belief that since HLL has achieved a sizeable scale of operations, going forward, it may not find it easy to achieve double digit topline growth, unless it chooses to grow inorganically.

    With the rain gods smiling, a better second half of FY02 is not ruled out. Thus these numbers may look better towards FY02 close. At the current market caps, the sector sample trades at a P/e of 24.5 times annualised June quarter earnings.

     

     

    Equitymaster requests your view! Post a comment on "Food sector: HLL trims growth". Click here!

      
     

    More Views on News

    GSK Consumer: On the Recovery Path (Quarterly Results Update - Detailed)

    Jun 20, 2017

    While GSK consumer reported muted revenue growth, volumes are seen to be recovering.

    ITC: Demonetisation woes pull down business growth (Quarterly Results Update - Detailed)

    Feb 8, 2017

    ITC Ltd has announced third quarter results of the financial year 2016-2017 (3QFY17). The company has reported 4.7% YoY and 5.7% YoY growth in revenues and net profits respectively. Here is our analysis of the results.

    ITC: A Decent Quarter Amidst Challenging Environment (Quarterly Results Update - Detailed)

    Dec 7, 2016

    ITC has announced second quarter results of the financial year 2016-2017 (2QFY17). The company has reported 8% YoY and 10.5% YoY growth in revenues and net profits respectively.

    ITC: Numbers Go Nowhere in FY16... (Quarterly Results Update - Detailed)

    Jun 8, 2016

    ITC declared results for the quarter and year ended March 2016. During the year, the company's net revenues and profits rise by 1% YoY and 3% YoY respectively.

    GSK Consumer: A Forgetful Year (Quarterly Results Update - Detailed)

    Jun 1, 2016

    GSK Consumer Healthcare announced its results for the quarter and year ended March 2016. During the quarter, sales and profit came in lower by 9% YoY and 8% YoY respectively.

    More Views on News

    Most Popular

    Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

    Aug 7, 2017

    The data tells us quite a different story from the one the government is trying to project.

    A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

    Aug 10, 2017

    Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

    Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

    Aug 8, 2017

    Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

    Signs of Life in the India VIX(Daily Profit Hunter)

    Aug 12, 2017

    The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

    7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

    Aug 7, 2017

    Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

    More
    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
     

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms

    COMPARE COMPANY

    MARKET STATS